The Gross Margin of Marinus Pharmaceuticals Inc (MRNS) is 93.76%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 93.76% |
2022-12-31 | 94.07% |
2021-12-31 | 90.36% |
2020-12-31 | 90.37% |